Many users reach their lowest weight within about 1 year
3 Months $1500
If affordability is a concern, talk to your doctor about whether a lower-cost option or patient assistance program makes sense for your situation
In a Phase I clinical trial, a PYY analog named Y14 peptide was administered subcutaneously every 7 to 14 days
Stopping semaglutide often leads to weight regain, so some people may take it indefinitely
This is a complex analysis involving a deep understanding of medicine, pharmacology and medication side effects, and the patients holistic health situation, factoring in their medical history, family history, other medications, previous attempts at weight loss, and environmental factors